SEO URLwww.firestrike.ai/deals/repare-therapeutics-xenotherapeutics-acquisition-2026-1
acquisitionAnnounced · Jan 27, 2026BiotechnologySource · CredibleArticle · Factual
XenoTherapeutics acquires Repare Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$95.1M
Target
Repare Therapeutics
NASDAQ: RPTX · Montreal, Quebec
Acquirer
XenoTherapeutics
Full Acquisition
Status
Completed
XenoTherapeutics agreed to acquire Repare Therapeutics. Reported deal value: $95.1M. Status: Completed. Sector: Biotechnology. Target headquarters context: Montreal, Quebec, Canada.
This page summarizes publicly available information about the transaction as of 2026-01-27. Figures and status may change as filings and press coverage update.
Xenotherapeutics Inc signed a definitive arrangement agreement to acquire Repare Therapeutics Inc . from BVF Partners L.P. , Blue Owl Healthcare Opportunities , OrbiMed Advisors LLC , and others for $78.7 million on November 14, 2025
Deal timeline
Announced
Jan 27, 2026 · in.marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $95.1M. Figures and status may change as sources update.
Sources: in.marketscreener.com · Primary article · FireStrike proprietary index